Insmed | INSM - EPS Earnings Per Share


Insmed reported $-1.54 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.99 -1.42 Apr/30 2026
FY2025Q4 Dec/2025 -1.54 -1.28 -1.32 Feb/19 2026
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30 2025
FY2025Q2 Jun/2025 -1.70 -1.36 -1.94 Aug/07 2025
FY2025Q1 Mar/2025 -1.42 -1.20 -1.06 May/08 2025




Eps Change Date
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Novartis USD 2.02 0.04 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025